Allergy Therapeutics (AGY) RNS Announcements

Add to Alert list
Date Time Source Announcement
21 Nov 2017 07:00 AM
RNS
Block Listing Application
13 Nov 2017 07:00 AM
RNS
Allergy Therapeutics to Present at Jefferies 2017
07 Nov 2017 12:59 PM
RNS
Director/PDMR Shareholding
07 Nov 2017 11:54 AM
RNS
Director/PDMR Shareholding
19 Oct 2017 04:14 PM
RNS
Publication of Annual Report and notice of AGM
19 Oct 2017 07:00 AM
RNS
Commencement of dosing in PQ Grass Phase II Trial
12 Oct 2017 05:39 PM
RNS
Holding(s) in Company
12 Oct 2017 02:55 PM
RNS
Director/PDMR Shareholding
10 Oct 2017 07:15 AM
RNS
Hardman Research: Continuing to gain market share
28 Sep 2017 07:00 AM
RNS
Preliminary Results
18 Sep 2017 07:00 AM
RNS
Approval for PQ Grass Phase II trial
11 Sep 2017 07:00 AM
RNS
Expansion of Clinical Development and R&D teams
15 Aug 2017 07:00 AM
RNS
Notice of Results
18 Jul 2017 07:00 AM
RNS
Trading Update
06 Jul 2017 07:00 AM
RNS
Publication of adjuvant studies in journals
27 Jun 2017 07:00 AM
RNS
Investor and analyst site visits
19 Jun 2017 07:00 AM
RNS
Satellite Symposium at EAACI 2017
06 Jun 2017 07:00 AM
RNS
Directorate changes
02 Jun 2017 12:55 PM
RNS
Holding(s) in Company
13 Apr 2017 07:00 AM
RNS
Issue of Equity
05 Apr 2017 07:15 AM
RNS
Hardman Research: Development across portfolio
29 Mar 2017 07:00 AM
RNS
Interim Results for six months ended 31 Dec 2016
16 Mar 2017 07:00 AM
RNS
First Patient in Pivotal Phase III Birch Study
09 Mar 2017 07:00 AM
RNS
Notice of Interim Results
14 Feb 2017 07:00 AM
RNS
House Dust Mite Allergy Vaccine Gains CTA Approval
08 Feb 2017 07:00 AM
RNS
Directorate Change
01 Feb 2017 07:00 AM
RNS
Positive Efficacy & Safety Data in Peanut Vaccine
20 Jan 2017 07:15 AM
RNS
Hardman Research: Investment driving market share
19 Jan 2017 07:00 AM
RNS
Trading Update
30 Dec 2016 02:31 PM
RNS
Grant of Awards
24 Nov 2016 05:23 PM
RNS
Result of AGM
02 Nov 2016 07:00 AM
RNS
EU Patent Office grants patent for MCT
27 Oct 2016 01:10 PM
RNS
Issue of equity in respect of exercise of options
24 Oct 2016 01:35 PM
RNS
Annual Report and Accounts
10 Oct 2016 07:00 AM
RNS
New data from novel adjuvant system
03 Oct 2016 11:28 AM
RNS
Issue of equity in respect of exercise of options
29 Sep 2016 12:40 PM
RNS
Director/PDMR Shareholding
28 Sep 2016 07:00 AM
RNS
Director/PDMR Shareholding
26 Sep 2016 11:59 AM
RNS
Director/PDMR Shareholding
26 Sep 2016 10:46 AM
RNS
Hardman Research: Performance drives market share
26 Sep 2016 07:00 AM
RNS
Allergy Therapeutics Preliminary Results
20 Sep 2016 04:58 PM
RNS
Issue of equity in respect of exercise of options
05 Sep 2016 07:00 AM
RNS
Notice of Preliminary Results
13 Jul 2016 07:00 AM
RNS
Trading Update
08 Jul 2016 07:00 AM
RNS
Results of mite immunotherapy Acarovac PlusT
27 Jun 2016 07:00 AM
RNS
Findings from mEEC dose range finding study G204
13 Jun 2016 07:00 AM
RNS
Allergy hosts Satellite Symposium at EAACI
10 Jun 2016 07:00 AM
RNS
Appointment of Finance Director
09 May 2016 07:00 AM
RNS
Positive Phase II Data
23 Mar 2016 09:02 AM
RNS
Issue of equity in respect of options exercise
UK 100

Latest directors dealings